#february2020mccqe1
A 40-year-old woman is evaluated for worsening asthma symptoms after resolution of an acute respiratory tract infection that was treated with supportive measures. The patient has a 15-year history of asthma that has been well controlled on moderate-dose inhaled corticosteroids plus as-needed inhaled albuterol. Since her respiratory tract infection 10 days ago, her asthma symptoms have worsened; she has had frequent nighttime episodes of wheezing and has used her albuterol inhaler six to eight times a day. On physical examination, the patient is afebrile and has no chest pain or significant sputum production. Her peak flow is more than 40% below her baseline value.
Which of the following is the most appropriate management for this patient?
(A) 7-Day course of a fluoroquinolone
(B) Leukotriene-modifying agent
(C) Long-acting β-agonist
(D) Nebulized albuterol at home
(E) Short course of an oral corticosteroid
A 40-year-old woman is evaluated for worsening asthma symptoms after resolution of an acute respiratory tract infection that was treated with supportive measures. The patient has a 15-year history of asthma that has been well controlled on moderate-dose inhaled corticosteroids plus as-needed inhaled albuterol. Since her respiratory tract infection 10 days ago, her asthma symptoms have worsened; she has had frequent nighttime episodes of wheezing and has used her albuterol inhaler six to eight times a day. On physical examination, the patient is afebrile and has no chest pain or significant sputum production. Her peak flow is more than 40% below her baseline value.
Which of the following is the most appropriate management for this patient?
(A) 7-Day course of a fluoroquinolone
(B) Leukotriene-modifying agent
(C) Long-acting β-agonist
(D) Nebulized albuterol at home
(E) Short course of an oral corticosteroid
Last edited by a moderator: